Statistics
Publications
2
Citations
46
H-Index
2
Active since
2023
Affiliations
Nanjing Medical University(Current)
Chang Liu is an author at Nanjing Medical University specializing in combination immunotherapy, synergistic immunotherapy mechanisms, and cancer immunotherapy.
Publications per year
2023–2024
2
2
Deubiquitinase inhibitor PR‐619 potentiates colon cancer immunotherapy by inducing ferroptosis
Jingjing Wu, Chang Liu, Tao Wang et al. · Immunology · 2023 · 18 citations · Full text
Medicine, Immunology, Oncology +17
1–2 of 2